C.R. Bard (NYSE: BCR) stock soared 19.5% higher on Monday after medical supply giant Becton, Dickinson (NYSE: BDX) announced it's acquiring the company for about $24 billion in cash and stock. It's an ...
Healthcare products maker and marketer C.R. Bard (NYSE: BCR) in Murray Hill acquired substantially all the assets of SourceTech Medical in Carol Stream, Illinois. Terms of the deal were not disclosed.
COLONIE — Latham's AngioDynamics is alleging that a major competitor in the medical device market, C.R. Bard, is violating anti-trust laws in the sale of its catheters. In a lawsuit filed in U.S.
NEW YORK (Reuters) - U.S. medical equipment supplier Becton Dickinson and Co (BDX.N) will acquire C R Bard Inc (BCR.N), in a $24 billion (£18.72 billion) cash-and-stock deal, adding Bard's devices to ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
A company that failed to adequately inform women of dangerous side effects related to permanent pelvic mesh devices will be required to pay $60 million, according to a settlement announced this week ...
MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE:BCR) today announced the LUTONIX® 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval (PMA) by the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results